SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-032815
Filing Date
2024-07-24
Accepted
2024-07-24 16:05:28
Documents
16
Period of Report
2024-07-24
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K sgmo-20240724.htm   iXBRL 8-K 32881
2 EX-99.1 exhibit-991072424.htm EX-99.1 29178
7 GRAPHIC logoa.gif GRAPHIC 43773
  Complete submission text file 0001628280-24-032815.txt   287954

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20240724.xsd EX-101.SCH 2197
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgmo-20240724_def.xml EX-101.DEF 15308
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20240724_lab.xml EX-101.LAB 27197
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20240724_pre.xml EX-101.PRE 16010
19 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20240724_htm.xml XML 2811
Mailing Address 501 CANAL BLVD. RICHMOND CA 94084
Business Address 501 CANAL BLVD. RICHMOND CA 94084 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 241138106
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)